620 filings
Page 3 of 31
4
cgruisldnr778g1lz7
4 Aug 23
NeuBase Therapeutics / Dietrich A Stephan ownership change
4:39pm
8-K
htfio1p4
3 Aug 23
NeuBase Therapeutics to Explore Strategic Alternatives
7:05am
UPLOAD
uua askayccb3vx
3 Aug 23
Letter from SEC
12:00am
8-K
oawc7g
31 Jul 23
Departure of Directors or Certain Officers
4:10pm
S-1
xkrq cjwddstv55
28 Jul 23
IPO registration
6:03am
D
26drvp6no hza
7 Jul 23
Exempt offering of security
4:11pm
8-K
505ofc1208s5ht c2eeq
30 Jun 23
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
4:21pm
424B5
m7shxr8 je
30 Jun 23
Prospectus supplement for primary offering
8:42am
424B3
a68uv5kk d6vpo
30 Jun 23
Prospectus supplement
8:41am
8-K
pbyvsg 66p8s
14 Jun 23
NeuBase Announces 1-for-20 Reverse Stock Split
4:10pm
10-QT
tommpl bfv7z
5 Jun 23
Quarterly report for transitional period
4:05pm
8-K
x6udd 47t2
22 May 23
Regulation FD Disclosure
7:00am
8-K
z4wg2 utq6ewn0u
18 May 23
Departure of Directors or Certain Officers
4:05pm
8-K
jg6n fpis39r
11 May 23
NeuBase Reports Business Update and Financial Results for the First Quarter of 2023
4:20pm
8-K
ufu5q49f45s9
24 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
grrfjso
29 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:04pm
UPLOAD
xmz5w858 3s
20 Mar 23
Letter from SEC
12:00am
4
9aehlorpsra
17 Mar 23
NeuBase Therapeutics / Todd P. Branning ownership change
4:11pm